Idongesit Aniekan Ekpo is a researcher in Pharmaceutical Technology with expertise in nanotechnology-driven cancer therapeutics. His doctoral work focuses on the formulation and characterization of nanoparticle-based drug delivery systems and their evaluation using breast cancer tumor cell lines (MCF-7). With advanced training in Medical Biochemistry and Clinical Biochemistry, his research integrates molecular mechanisms of cancer progression with innovative pharmaceutical formulation strategies. He is particularly interested in targeted drug delivery, controlled release systems, tumor microenvironment interactions, and translational nanomedicine.